- Affirmative Recovery
- Alternative Dispute Resolution
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
September 22, 2020New York Law Journal Recognizes Hollis Salzman as a Trailblazer
-
September 18, 2020Teresa Fariss Mcclain Recognized as Woman worth Watching by Profiles in Diversity Journal
-
September 17, 2020Robins Kaplan LLP Files New Lawsuit Against Delbarton School and the Order of St. Benedict of New Jersey on behalf of Survivors of Child Sex Abuse
-
September 29, 2020The Profound Importance of Authentic Leadership, Especially During a Crisis
-
September 29, 2020Turnaround Management Association (TMA) IMPACT 2020 Global Conference
-
September 30, 2020From Contract to Courtroom: Lessons Learned in Contract Litigation and Trials
-
Summer 2020Following a Varied Legal Career, Judge Jonathan Kobes Begins on the Eighth Circuit
-
September 22, 2020Herbal Patent Protection
-
August 24, 2020Hot off the Presses: California Further Regulates Out-of-State Adjusters in the Wake of Record-Breaking Catastrophic Losses
Jamie R. Kurtz
Jamie R. Kurtz
Partner
Experience
Jamie is a trial attorney that primarily focuses her practice on intellectual property and heath care litigation. Jamie currently represents various healthcare plans in multi-million-dollar litigation with providers involving claims improper billing, breach of contract, and fraud. In the IP space, she has represented clients ranging from individual business owners to Fortune 500 companies in matters involving numerous technologies ranging from pharmaceuticals and medical devices MRI technology to windshield washer fluid. In all areas, Jamie uses her technical background to help clients develop their case and develop an appropriate strategy to achieve their business goals.
Jamie attended law school at the University of Minnesota, where she graduated magna cum laude. While in law school, Jamie also attended graduate school where she received her M.S. in Pharmacology. Jamie’s Master’s project was focused on studying the toxic effect of DNA-Protein crosslinks caused by various types of drugs.
PCT International Inc. v. Holland Electronics LLC. Represented plaintiff in a patent infringement case involving coaxial cable connector technology. Won a jury verdict of infringement in May of 2015.
Defense counsel for Upsher-Smith Laboratories in Auxilium Pharmaceuticals v. Upsher-Smith Laboratories, a Hatch-Waxman patent infringement case in which we obtained a summary judgment of non-infringement of ten patents claiming a transdermal testosterone gel and method of treating hypogonadism before Judge Sue Robinson of the Federal District Court in Delaware. The opinion was filed on December 4, 2013. The technology related to claimed macrocyclic penetration enhancers for increasing the rate of passage of an androgen through the skin. We were successful in demonstrating to the Court that the case warranted an exception to the Court’s ordinary practice of declining to hear summary judgment motions in Hatch-Waxman cases.
Wisconsin Alumni Research Foundation v. Siemens AG, et al. Represented the Wisconsin Alumni Research foundation in a case involving magnetic resonance imaging (MRI) technology. Settled for value.
Promega Corp. v. Applied Biosystems, LLC, et al. Represented Promega in a case involving DNA analysis technologies. Won summary judgment of invalidity of all asserted claims.
Forest Laboratories, Inc. v. Torrent Pharmaceuticals Ltd. Represented client in litigation to bring generic Bystolic® (nebivolol) to market. Settled for value.
- Named an "Associate to Watch," Chambers (2017)
- Named a "Minnesota Rising Star," Super Lawyers (2015-2020)
- Minnesota
- U.S. Court of Appeals, Federal Circuit
- U.S. Court of Appeals, Ninth Circuit
- U.S. District Court, Minnesota
- “Upsher-Smith Secures Summary Judgment Noninfringement Ruling on Testim Patents,” Bloomberg BNA Pharmaceutical Law & Industry Report, Vol. 11, No. 48 (December 13, 2013)
- A Practical Guide for Assessing and Responding to Potential Data Breach
10th Annual Advanced Forum on Managed Care Disputes and Litigation, Chicago, Illinois (May 17, 2019)
RESOURCES
PUBLICATIONS
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.